Summit Trail Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.1M Buy
102,792
+20,623
+25% +$4.8M 0.36% 37
2025
Q4
$17M Sell
82,169
-7,199
-8% -$1.42M 0.29% 44
2025
Q3
$16.6M Buy
89,368
+8,443
+10% +$1.45M 0.23% 50
2025
Q2
$12.4M Buy
+80,925
New +$12.4M 0.21% 59
2024
Q4
Sell
-53,162
Closed -$8.62M 584
2024
Q3
$8.62M Buy
53,162
+7,242
+16% +$1.15M 0.21% 51
2024
Q2
$6.71M Buy
45,920
+10,789
+31% +$1.6M 0.18% 52
2024
Q1
$5.56M Buy
35,131
+16,713
+91% +$2.66M 0.15% 57
2023
Q4
$2.89M Sell
18,418
-3,391
-16% -$520K 0.1% 81
2023
Q3
$3.4M Buy
21,809
+1,707
+8% +$282K 0.13% 65
2023
Q2
$3.33M Buy
20,102
+7,836
+64% +$1.26M 0.13% 65
2023
Q1
$1.9M Buy
12,266
+578
+5% +$93.3K 0.08% 88
2022
Q4
$2.06M Buy
11,688
+592
+5% +$102K 0.09% 74
2022
Q3
$1.81M Sell
11,096
-699
-6% -$118K 0.1% 73
2022
Q2
$2.09M Buy
11,795
+5,808
+97% +$1.03M 0.13% 78
2022
Q1
$1.06M Buy
5,987
+1,501
+33% +$255K 0.09% 101
2021
Q4
$767K Buy
4,486
+124
+3% +$20.3K 0.05% 145
2021
Q3
$704K Buy
4,362
+1,432
+49% +$244K 0.05% 139
2021
Q2
$483K Sell
2,930
-807
-22% -$134K 0.04% 141
2021
Q1
$614K Sell
3,737
-344
-8% -$55.7K 0.07% 107
2020
Q4
$642K Sell
4,081
-2,116
-34% -$312K 0.08% 97
2020
Q3
$919K Buy
6,197
+2,699
+77% +$399K 0.18% 64
2020
Q2
$492K Buy
3,498
+1,043
+42% +$152K 0.09% 91
2020
Q1
$322K Buy
+2,455
New +$348K 0.09% 89
2018
Q2
Sell
-16,927
Closed -$1.77M 567
2018
Q1
$1.77M Buy
16,927
+1,936
+13% +$262K 0.3% 69
2017
Q4
$2.12M Buy
+14,991
New +$2.09M 0.27% 71

Other funds holding JNJ

Summit Trail Advisors's JNJ Position: Q1 2026 in Review

Summit Trail Advisors increased its Johnson & Johnson (JNJ) stake by 25% in Q1 2026, buying an estimated $4.8M and bringing the position to 102,792 shares worth $25.1M. The position accounts for 0.36% of the portfolio, ranked #37.

Summit Trail Advisors first reported a position in JNJ in Q4 2017 and has held it in 25 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Summit Trail Advisors held 102,792 shares of Johnson & Johnson worth $25.1M as of Q1 2026.
  • Summit Trail Advisors bought 20,623 Johnson & Johnson shares in Q1 2026, an estimated $4.8M.
  • Johnson & Johnson made up 0.36% of Summit Trail Advisors's portfolio in Q1 2026, its #37 holding.
  • Summit Trail Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 25 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.